Cell cycle-dependent translation of p27 involves a responsive element in its 5′-UTR that overlaps with a uORF

Human Molecular Genetics

Volumn 12, Issue 14, 2003, Pages 1767-1779

  Göpfert, Ulrich ^a   Kullmann, Michael ^a   Hengst, Ludger ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOSINE; GUANINE; PROTEIN P27; RNA; UBIQUITIN;

5' UNTRANSLATED REGION; ANIMAL CELL; BREAST CARCINOMA; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHICKEN; COLON CARCINOMA; CONTROLLED STUDY; GC RICH SEQUENCE; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MITOSIS INHIBITION; MODULATION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; RNA TRANSLATION; SEQUENCE ANALYSIS; START CODON; STOMACH CARCINOMA; TRANSLATION REGULATION;

5' UNTRANSLATED REGIONS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HELA CELLS; HUMANS; OPEN READING FRAMES; PROTEIN BIOSYNTHESIS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; GALLUS GALLUS;

EID: 0041308069     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg177     Document Type: Review

References (90)

1. Ekholm, S.V. and Reed, S.I. (2000) Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol., 12, 676-684.
2. Morgan, D.O. (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. A. Rev. Cell Dev. Biol., 13, 261-291.
3. Kaldis, P. (1999) The cdk-activating kinase (CAK): from yeast to mammals. Cell Mol. Life Sci., 55, 284-296.
4. Lew, D.J. and Kornbluth, S. (1996) Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol., 8, 795-804.
5. Nilsson, I. and Hoffmann, I. (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res., 4, 107-114.
6. Carnero, A. and Hannon, G.J. (1998) The INK4 family of CDK inhibitors. Curr. Top. Microbiol. Immunol., 227, 43-55.
7. Jeffrey, P.D., Tong, L. and Pavletich, N.P. (2000) Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev., 14, 3115-3125.
8. Hengst, L. and Reed, S.I. (1998) Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol., 227, 25-41.
9. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
10. Sherr, C.J. and Roberts, J.M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev., 13, 1501-1512.
11. Russo, A.A., Jeffrey, P.D., Patten, A.K., Massague, J. and Pavletich, N.P. (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature, 382, 325-331.
12. Hengst, L., Göpfert, U., Lashuel, H.A. and Reed, S.I. (1998) Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev., 12, 3882-3888.
13. Soos, T.J., Kiyokawa, H., Yan, J.S., Rubin, M.S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J. and Koff, A. (1996) Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ., 7, 135-136.
14. Blain, S.W., Montalvo, E. and Massague, J. (1997) Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem., 272, 25863-25872.
15. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862.
16. Cheng, M., Olivier, P., Diehl, J.A., Fero, M., Roussel, M.F., Roberts, J.M. and Sherr, C.J. (1999) The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J., 18, 1571-1583.
17. Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P. and Massague, J. (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
18. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M. and Koff, A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
19. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. and Reed, S.I. (1994) A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl Acad. Sci. USA, 91, 5291-5295.
20. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
21. Harper, J.W., Elledge, S.J., Keyomarsi, K., Dynlacht, B., Tsai, L.H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E. et al. (1995) Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6, 387-400.
22. Slingerland, J.M., Hengst, L., Pan, C.H., Alexander, D., Stampfer, M.R. and Reed, S.I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol., 14, 3683-3694.
23. Coats, S., Flanagan, W.M., Nourse, J. and Roberts, J.M. (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 877-880.
24. Rivard, N., L'Allemain, G., Bartek, J. and Pouyssegur, J. (1996) Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem., 271, 18337-18341.
25. Fero, M.L., Rivkin, M., Tasch, M., Porter, P., Carow, C.E., Firpo, E., Polyak, K., Tsai, L.H., Broudy, V., Perlmutter, R.M. et al. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell, 85, 733-744.
26. Kiyokawa, H., Kineman, R.D., Manova-Todorova, K.O., Soares, V.C., Hoffman, E.S., Ono, M., Khanam, D., Hayday, A.C., Frohman, L.A. and Koff, A. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell, 85, 721-732.
27. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I. and Loh, D.Y. (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707-720.
28. Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. and Kemp, C.J. (1998) The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature, 396, 177-180.
29. Inoue, T., Kamiyama, J. and Sakai, T. (1999) Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J. Biol. Chem., 274, 32309-32317.
30. Shaffer, A.L., Yu, X., He, Y., Boldrick, J., Chan, E.P. and Staudt, L.M. (2000) BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity, 13, 199-212.
31. Kolluri, S.K., Weiss, C., Koff, A. and Gottlicher, M. (1999) p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev., 13, 1742-1753.
32. Medema, R.H., Kops, G.J., Bos, J.L. and Burgering, B.M. (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 404, 782-787.
33. Agrawal, D., Hauser, P., McPherson, F., Dong, F., Garcia, A. and Pledger, W.J. (1996) Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol., 16, 4327-4336.
34. Millard, S.S., Yan, J.S., Nguyen, H., Pagano, M., Kiyokawa, H. and Koff, A. (1997) Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem., 272, 7093-7098.
35. Hengst, L. and Reed, S.I. (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science, 271, 1861-1864.
36. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F. and Rolfe, M. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
37. Hara, T., Kamura, T., Nakayama, K., Oshikawa, K. and Hatakeyama, S. (2001) Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem., 276, 48937-48943.
38. Malek, N.P., Sundberg, H., McGrew, S., Nakayama, K., Kyriakides, T.R., Roberts, J.M. and Kyriakidis, T.R. (2001) A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature, 413, 323-327.
39. Rodier, G., Montagnoli, A., Di Marcotullio, L., Coulombe, P., Draetta, G.F., Pagano, M. and Meloche, S. (2001) p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J., 20, 6672-6682.
40. Kip1 involves a nuclear export signal and links p27 export and proteolysis. Mol. Biol. Cell, 14, 201-213.
41. Viglietto, G., Motti, M.L., Bruni, P., Melillo, R.M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A. et al. (2002) Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med., 8, 1136-1144.
42. Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M.K., Han, K., Lee, J.H., Ciarallo, S., Catzavelos, C., Beniston, R. et al. (2002) PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med., 8, 1153-1160.
43. Shin, I., Yakes, F.M., Rojo, F., Shin, N.Y., Bakin, A.V, Baselga, J. and Arteaga, C.L. (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med., 8, 1145-1152.
44. Harper, J.W. (2001) Protein destruction: adapting roles for Cks proteins. Curr. Biol., 11, R431-435.
45. Sheaff, R.J., Singer, J.D., Swanger, J., Smitherman, M., Roberts, J.M. and Clurman, B.E. (2000) Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell, 5, 403-410.
46. Vlach, J., Hennecke, S. and Amati, B. (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J., 16, 5334-5344.
47. Ishida, N., Kitagawa, M., Hatakeyama, S. and Nakayama, K. (2000) Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J. Biol. Chem., 275, 25146-25154.
48. Müller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W. and Eilers, M. (1997) Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576.
49. Miskimins, W.K., Wang, G., Hawkinson, M. and Miskimins, R. (2001) Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation. Mol. Cell. Biol., 21, 4960-4967.
50. Kullmann, M., Göpfert, U., Siewe, B. and Hengst, L. (2002) ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev., 16, 3087-3099.
51. Vidal, A., Millard, S.S., Miller, J.P. and Koff, A. (2002) Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J. Biol. Chem., 277, 16433-16440.
52. Minami, S., Ohtani-Fujita, N., Igata, E., Tamaki, T. and Sakai, T. (1997) Molecular cloning and characterization of the human p27Kip1 gene promoter. FEBS Lett., 411, 1-6.
53. Ito, E., Iwahashi, Y., Yanagisawa, Y., Suzuki, Y., Sugano, S., Yuasa, Y. and Maruyama, K. (1999) Two short sequences have positive effects on the human p27Kip1 gene transcription. Gene, 228, 93-100.
54. Kamiyama, J., Inoue, T., Ohtani-Fujita, N., Minami, S., Yamagishi, H. and Sakai, T. (1999) The ubiquitous transcription factor NF-Y positively regulates the transcription of human p27Kip1 through a CCAAT box located in the 5-upstream region of the p27Kip1 gene. FEBS Lett., 455, 281-285.
55. Millard, S.S., Vidal, A., Markus, M. and Koff, A. (2000) A U-rich element in the 5′ untranslated region is necessary for the translation of p27 mRNA. Mol. Cell. Biol., 20, 5947-5959.
56. Willis, A.E. (1999) Translational control of growth factor and proto-oncogene expression. Int. J. Biochem. Cell Biol., 31, 73-86.
57. Calkhoven, C.F., Muller, C. and Leutz, A. (2000) Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev., 14, 1920-1932.
58. Calkhoven, C., Müller, C., Martin, R., Krosl, G., Hoang, T. and Leutz, A. (2003) Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes Dev., 17, 959-964.
59. Geballe, A.P. and Sachs, M.S. (2000) Translational control by upstream open reading frames. In Sonenberg, N., Hershey, J.W.B. and Mathews, M.B. (eds), Translational Control of Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 595-614.
60. Horvath, P., Suganuma, A., Inaba, M., Pan, Y.B. and Gupta, K.C. (1995) Multiple elements in the 5′ untranslated region down-regulate c-sis messenger RNA translation. Cell Growth Differ., 6, 1103-1110.
61. Kozak, M. (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell, 44, 283-292.
62. Kozak, M. (1999) Initiation of translation in prokaryotes and eukaryotes. Gene, 234, 187-208.
63. Stoneley, M., Subkhankulova, T., Le Quesne, J.P., Coldwell, M.J., Jopling, C.L., Belsham, G.J. and Willis, A.E. (2000) Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment. Nucl. Acids Res., 28, 687-694.
64. Hunt, S.L. and Jackson, R.J. (1999) Polypyrimidine-tract binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA. RNA, 5, 344-359.
65. Hunt, S.L., Hsuan, J.J., Totty, N. and Jackson, R.J. (1999) unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains, is required for internal initiation of translation of human rhinovirus RNA. Genes Dev., 13, 437-448.
66. Morris, D.R. and Geballe, A.P. (2000) Upstream open reading frames as regulators of mRNA translation. Mol. Cell. Biol., 20, 8635-8642.
67. Dever, T.E. (2002) Gene-specific regulation by general translation factors. Cell, 108, 545-556.
68. Polymenis, M. and Schmidt, E.V. (1997) Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev., 11, 2522-2531.
69. Kozak, M. (1989) Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell. Biol., 9, 5134-5142.
70. Rijnbrand, R., Bredenbeek, P., van der Straaten, T., Whetter, L., Inchauspe, G., Lemon, S. and Spaan, W. (1995) Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett., 365, 115-119.
71. Yu, H., Isken, O., Grassmann, C.W. and Behrens, S.E. (2000) A stem-loop motif formed by the immediate 5′ terminus of the bovine viral diarrhea virus genome modulates translation as well as replication of the viral RNA. J. Virol., 74, 5825-5835.
72. Svitkin, Y.V., Pause, A. and Sonenberg, N. (1994) La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol., 68, 7001-7007.
73. Viglietto, G., Motti, L.M. and Fusco, A. (2002) Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization? Cell Cycle, 1, 394-400.
74. Bloom, J. and Pagano, M. (2003) Deregulated degradation of the cdkinhibitor p27 and malignant transformation. Sem. Cancer Biol., 13, 41-47.
75. Tsihlias, J., Kapusta, L. and Slingerland, J. (1999) The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. A. Rev. Med., 50, 401-423.
76. Steeg, P.S. and Abrams, J.S. (1997) Cancer prognostics: past, present and p27. Nat. Med., 3, 152-154.
77. Philipp-Staheli, J., Payne, S.R. and Kemp, C.J. (2001) p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res., 264, 148-168.
78. Hwang, H.C., Martins, C.P., Bronkhorst, Y., Randel, E., Berns, A., Fero, M. and Clurman, B.E. (2002) Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc. Natl Acad. Sci. USA, 99, 11293-11298.
79. Blain, S.W. and Massague, J. (2002) Breast cancer banishes p27 from nucleus. Nat. Med., 8, 1076-1078.
80. Slingerland, J. and Pagano, M. (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol., 183, 10-17.
81. Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J. and Krek, W. (2001) Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl Acad. Sci. USA, 98, 5043-5048.
82. Calkhoven, C.F., Muller, C. and Leutz, A. (2002) Translational control of gene expression and disease. Trends Mol. Med., 8, 577-583.
83. Lennon, G., Auffray, C., Polymeropoulos, M. and Soares, M.B. (1996) The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics, 33, 151-152.
84. Ho, S., Hunt, H., Horton, R., Pullen, J. and Pease, L. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, 77, 51-59.
85. Hengst, L., Lehmeier, T. and Gallwitz, D. (1990) The ryh1 gene in the fission yeast Schizosaccharomyces pombe encoding a GTP-binding protein related to ras, rho and ypt: structure, expression and identification of its human homologue. EMBO J., 9, 1949-1955.
86. Walter, A.E., Turner, D.H., Kim, J., Lyttle, M.H., Müller, P., Mathews, D.H. and Zuker, M. (1994) Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc. Natl Acad. Sci. USA, 91, 9218-9222.
87. Mathews, D.H., Sabina, J., Zuker, M. and Turner, D.H. (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol., 288, 911-940.
88. Zuker, M., Mathews, D. and Turner, D. (1999) Algorithms and thermodynamics for RNA secondary structure prediction: a practical guide. In Barciszewski, J. and Clark, B.F.C. (eds), RNA Biochemistry and Biotechnology. NATO ASI Series. Kluwer Academic, Dordrecht pp. 11-43.
89. Keyomarsi, K., Sandoval, L., Band, V. and Pardee, A.B. (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res., 51, 3602-3609.
90. Carroll, R. and Lucas-Lenard, J. (1993) Preparation of a cell-free translation system with minimal loss of initiation factor eIF-2/eIF-2B activity. Anal. Biochem., 212, 17-23.